Grantham, Mayo, Van Otterloo & Co (GMO)
PACB icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Pacific Biosciences PACB Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,810,217
Closed -$9.34M – 746
2019
Q3 		$9.34M Buy
1,810,217
+763,574
+73% +$4.27M 0.06% 195
2019
Q2 		$6.33M Buy
+1,046,643
New +$7.34M 0.04% 248
2019
Q1 		– Sell
-31,900
Closed -$236K – 736
2018
Q4 		$236K Buy
+31,900
New +$202K ﹤0.01% 498

Other funds holding PACB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s PACB Position: Q4 2019 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Pacific Biosciences (PACB) in Q4 2019, closing a stake of 1,810,217 shares — an estimated $9.34M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PACB in Q4 2018 and held it in 3 quarters. The position peaked at $9.34M in Q3 2019. 143 funds tracked by Wall St. Rank hold PACB as of Q4 2019.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Pacific Biosciences position as of Q4 2019 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,810,217 Pacific Biosciences shares in Q4 2019, an estimated $9.34M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Pacific Biosciences in Q4 2018 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Pacific Biosciences position peaked at $9.34M in Q3 2019.
  • 143 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2019.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2019, filed 13 Feb 2020.